Kaleido Biosciences, Inc.

KLDO · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$90-$82-$86-$62
Dep. & Amort.$2$2$1$1
Deferred Tax-$0$0$0$1
Stock-Based Comp.$10$13$10$0
Change in WC-$0$5-$1$6
Other Non-Cash$1$1$0$0
Operating Cash Flow-$77-$62-$76-$46
Investing Activities
PP&E Inv.-$1-$4-$4-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$4-$4-$3
Financing Activities
Debt Repay.$0-$0$7-$0
Stock Issued$70$38$68$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$3-$1$99
Financing Cash Flow$70$40$75$99
Forex Effect$0$0$0$0
Net Chg. in Cash-$8-$25-$5$50
Supplemental Information
Beg. Cash$48$74$78$29
End Cash$41$48$74$78
Free Cash Flow-$78-$66-$79-$49
Kaleido Biosciences, Inc. (KLDO) Financial Statements & Key Stats | AlphaPilot